Risks and benefits of attention-deficit/hyperactivity disorder medication on behavioral and neuropsychiatric outcomes: a qualitative review of pharmacoepidemiology …

Z Chang, L Ghirardi, PD Quinn, P Asherson… - Biological …, 2019 - Elsevier
Attention-deficit/hyperactivity disorder (ADHD) medication is one of the most commonly
prescribed medication classes in child and adolescent psychiatry, and its use is increasing …

Emerging challenges in pharmacotherapy research on attention-deficit hyperactivity disorder—outcome measures beyond symptom control and clinical trials

ICK Wong, T Banaschewski, J Buitelaar… - The Lancet …, 2019 - thelancet.com
Although pharmacological therapies are recommended as a key component in the treatment
of attention-deficit hyperactivity disorder, their use continues to prompt intense debate …

A review of factors influencing the three phases of medication adherence in people with attention-deficit/hyperactivity disorder

MU Khan, P Aslani - Journal of Child and Adolescent …, 2019 - liebertpub.com
Objectives: Factors affecting adherence to medications in people with attention-
deficit/hyperactivity disorder (ADHD) are not well understood in the context of their influence …

Debate: are stimulant medications for attention-deficit/hyperactivity disorder effective in the long term?

S Cortese - Journal of the American Academy of Child and …, 2019 - europepmc.org
Attention-deficit/hyperactivity disorder (ADHD) is one of the most common diagnoses in child
and adolescent mental health services, in the United States as well as in many other …

Specific effects of individualized cognitive training in children with attention-deficit/hyperactivity disorder (ADHD): The role of pre-training cognitive impairment and …

F Minder, A Zuberer, D Brandeis… - Developmental …, 2019 - Taylor & Francis
Objective: We investigated the impact of the pre-training neuropsychological (NP)
impairment and of the training progress on the NP and behavioural outcome after …

[PDF][PDF] Psychosis during attention deficit–hyperactivity disorder treatment with stimulants

S Cortese - New England Journal of Medicine, 2019 - eprints.soton.ac.uk
Attention deficit–hyperactivity disorder (ADHD) is one of the most commonly diagnosed
conditions in child and adolescent mental health services. Stimulants, including …

Placental abruption and long‐term neurological hospitalisations in the offspring

G Pariente, T Wainstock, A Walfisch… - Paediatric and …, 2019 - Wiley Online Library
Background Placental abruption is a major determinant of maternal and perinatal morbidity
and mortality, often related to asphyxia and preterm birth. However, the impact of abruption …

Time for a New Conversation on Stimulant Use.

A Charach - Journal of the American Academy of Child and …, 2019 - europepmc.org
Psychostimulants are one of the safest and most efficacious pharmacological interventions
for a psychiatric disorder. In 1999, the groundbreaking Multimodal Treatment of Attention …

[HTML][HTML] A review of changes to the attention deficit/hyperactivity disorder age of onset criterion using the checklist for modifying disease definitions

S Sanders, R Thomas, P Glasziou, J Doust - BMC psychiatry, 2019 - Springer
Background Widening definitions of health conditions have the potential to affect millions of
people and should only occur when there is strong evidence of benefit. In the last version of …

[HTML][HTML] Prescribing for young people with attention deficit hyperactivity disorder in UK primary care: analysis of data from the Clinical Practice Research Datalink

T Newlove-Delgado, W Hamilton, TJ Ford… - ADHD Attention Deficit …, 2019 - Springer
Guidance on management of attention deficit hyperactivity disorder (ADHD) in the UK was
issued by the National Institute for Clinical Excellence in 2008. No UK study has examined …